Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Mosapride Formulations in Healthy Adults
NCT02201316Phase 1Completed
- Sponsor
- GSK
- Start
- Feb 2014
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of mosapride in gastritis (6 arms), sponsored by GSK. Primary endpoint: Composite of pharmacokinetics (PK) parameters of mosapride. Started Feb 2014; status: completed.
02
Drugs
mosapride
03
Conditions
gastritis
Beyond the preview
Go deeper on NCT02201316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02201316.